5 Key Takeaways

• 1

  Lenz Therapeutics received FDA approval for Vizz, an eye drop solution for treating presbyopia in adults.

• 2

  Vizz improves near vision within 30 minutes and effects last up to 10 hours.

• 3

  The treatment works by contracting the iris sphincter muscle to create a pinhole effect, enhancing depth of focus.

• 4

  Clinical trials CLARITY 1, 2, and 3 demonstrated Vizz's safety and efficacy with mild, transient adverse events.

• 5

  Commercial availability of Vizz is expected by mid-Q4 2025, with samples anticipated as early as October 2025.